Back to Search
Start Over
Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
- Source :
- PMC
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- An improved understanding of the anti-tumor CD8(+) T cell response after checkpoint blockade would enable more informed and effective therapeutic strategies. Here we examined the dynamics of the effector response of CD8(+) tumor-infiltrating lymphocytes (TILs) after checkpoint blockade therapy. Bulk and single-cell RNA profiles of CD8(+) TILs following combined Tim-3+PD-1 blockade in preclinical models revealed significant changes in the transcriptional profile of PD-1(−) TILs. These cells could be divided into subsets bearing characterstics of naïve-, effector-, and memory-precursor-like cells. Effector- and memory-precursor-like TILs contained tumor-antigen specific cells, exhibited proliferative and effector capacity and expanded in response to different checkpoint blockade therapies across different tumor models. The memory-precursor-like subset shared features with CD8(+) T cells associated with response to checkpoint blockade in patients, and was compromised in the absence of Tcf7. Expression of Tcf7/Tcf1 was requisite for the efficacy of diverse immunotherapies, highlighting the importance of this transcriptional regulator in the development of effective CD8(+) T cell responses upon immunotherapy.
- Subjects :
- 0301 basic medicine
Effector
T cell
medicine.medical_treatment
Immunology
Immunotherapy
Biology
Article
Blockade
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Infectious Diseases
medicine.anatomical_structure
030220 oncology & carcinogenesis
Cancer research
medicine
Transcriptional regulation
Immunology and Allergy
Cytotoxic T cell
Checkpoint Blockade Immunotherapy
CD8
Subjects
Details
- ISSN :
- 10747613
- Volume :
- 50
- Database :
- OpenAIRE
- Journal :
- Immunity
- Accession number :
- edsair.doi.dedup.....86ae86b83ab292ba44168cae62015d03